US Patent Issued to Tempus AI on March 24 for "Integrated machine-learning framework to estimate homologous recombination deficiency" (Illinois Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,584,176, issued on March 24, was assigned to Tempus AI Inc. (Chicago).

"Integrated machine-learning framework to estimate homologous recombination deficiency" was invented by Aarti Venkat (Chicago), Jerod Parsons (Chicago), Joshua SK Bell (Chicago), Catherine Igartua (Chicago), Yilin Zhang (Wilmette, Ill.), Ameen Salahudeen (Oak Park, Ill.), Veronica Sanchez Freire (Chicago) and Robert Tell (Chicago).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods, systems, and software are provided for determining a homologous recombination pathway status of a cancer in a test subject, e.g., to improve cancer treatment predictions and outcomes. In some embodimen...